Last updated:
Author(s):
Kate Townsend Creasy, Minal B. Mehta, Carolin V. Schneider, Joseph Park, David Zhang, Swapnil V. Shewale, John S. Millar, Marijana Vujkovic, Nicholas J. Hand, Paul M. Titchenell, Joseph A. Baur, Daniel J. Rader
Publish date:
16 May 2025
Journal:
Science Advances
PubMed ID:
40378221

Abstract

The PPP1R3B gene, encoding PPP1R3B protein, is critical for liver glycogen synthesis and maintaining blood glucose levels. Genetic variants affecting PPP1R3B expression are associated with several metabolic traits and liver disease, but the precise mechanisms are not fully understood. We studied the effects of both Ppp1r3b overexpression and deletion in mice and cell models and found that both changes in Ppp1r3b expression result in dysregulated metabolism and liver damage, with overexpression increasing liver glycogen stores, while deletion resulted in higher liver lipid accumulation. These patterns were confirmed in humans where variants increasing PPP1R3B expression had lower liver fat and decreased plasma lipids, whereas putative loss-of-function variants were associated with increased liver fat and elevated plasma lipids. These findings support that PPP1R3B is a crucial regulator of hepatic metabolism beyond glycogen synthesis and that genetic variants affecting PPP1R3B expression levels influence if hepatic energy is stored as glycogen or triglycerides.

Related projects

Cardiometabolic diseases such as cardiovascular disease, metabolic liver disease, diabetes mellitus and hypertension have a complex genetic etiology and often co-occur, which makes distinguishing causal…

Institution:
University of Pennsylvania, United States of America

All projects